Boston Scientific Corp (BSX) stock news · P/E 18, rev $20.07B
Boston Scientific Corp (BSX) is a medical devices company listed on US.
This BSX news page leads with what Boston Scientific Corp filed — not a scraped headline mill.
No cached 8-K sentence for BSX yet. We will not pad this page with generic market recap.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. Revenue was up 19.9% from 2024-12-31 to 2025-12-31. BSX currently screens at market cap $71.81B and trailing P/E 17.9.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BSX stock page; for the tape open the quote page.
BSX stock news FAQ
What are BSX's latest revenue and net income?
Latest cached Boston Scientific Corp (BSX) revenue for Dec 31, 2025 was $20.07B. Net income was $2.89B. Statements: https://lician.com/financials/bsx
How did BSX revenue change from the prior cached period?
Cached Boston Scientific Corp (BSX) revenue was up 19.9% from $16.75B (Dec 31, 2024) to $20.07B (Dec 31, 2025). Statements: https://lician.com/financials/bsx
What is BSX's P/E ratio?
Boston Scientific Corp (BSX) trailing P/E is 17.9 on the latest cached fundamentals snapshot.
What is BSX's market cap?
Boston Scientific Corp (BSX) market cap is $71.81B on the latest cached fundamentals snapshot.
What kind of company is BSX?
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Where is BSX stock news listed?
Cached stock news for Boston Scientific Corp (BSX) is listed at https://lician.com/news/bsx. Filings: https://lician.com/sec/bsx
Not investment advice.